|
hsa-miR-139-5p
|
AKT
|
Inhibits oral cancer cell proliferation and induces cell apoptosis
|
[36]
|
|
hsa-miR-17-5p
|
Casp-2/−7/− 8, Bcl-2 and DIALO
|
Inhibits hypoxia-induced apoptosis
|
[37]
|
|
hsa-miR-107
|
p53
|
p53 upregulates miR-107 in normal condition
|
[38]
|
|
hsa-miR-375
|
Sp1 and cyclin D1
|
Inhibits cell growth and its expression is correlatedwith prognosis of TSCC
|
[39]
|
|
hsa-miR-455-5p
|
UBE2B
|
Binds SMAD3-specific promoter regions, leads toUBE2B downregulation, and contributes to oralcancer tumorigenesis
|
[40]
|
|
hsa-miR-137
|
CDK6
|
Arrests cell cycle at the G1-S checkpoint
|
[41]
|
|
hsa-miR-140-5p
|
ADAM10
|
Inhibits the invasion and migration of TSCC cells
|
[42]
|
|
hsa-miR-125b-5p
|
BAK1
|
Boosts the level of BAK1 that is controlling the apoptotic pathway
|
[38]
|
